{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:49:58Z","timestamp":1789962598839,"version":"4.0.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1097\/01.jcp.0000138763.23482.2a","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T19:07:06Z","timestamp":1094584026000},"page":"532-535","source":"Crossref","is-referenced-by-count":75,"title":["Quetiapine for Treatment of Alcohol Dependence"],"prefix":"10.1097","volume":"24","author":[{"given":"Edward P.","family":"Monnelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenic A.","family":"Ciraulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"LoCastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaias","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"2","key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oxfordjournals.schbul.a033464","article-title":"The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.","volume":"26","author":"Drake","year":"2000","journal-title":"Schizophr Bull"},{"issue":"1","key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200002000-00016","article-title":"Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey.","volume":"20","author":"Zimmet","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-9964(02)00231-1","article-title":"Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone.","volume":"60","author":"Green","year":"2003","journal-title":"Schizophr Res"},{"issue":"4","key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0740-5472(01)00205-7","article-title":"Olanzapine treatment for patients with schizophrenia and substance abuse.","volume":"21","author":"Littrell","year":"2001","journal-title":"J Subst Abuse Treat"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.jcp.0000085417.08426.54","article-title":"Potential use of olanzapine in treatment of substance dependence disorder.","volume":"23","author":"Sattar","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002130000629","article-title":"Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol.","volume":"155","author":"Hutchison","year":"2001","journal-title":"Psychopharmacology"},{"issue":"suppl 13","key":"R8-10-20210128","first-page":"5","article-title":"Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.","volume":"63","author":"Nemeroff","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14656566.1.4.783","article-title":"Review of quetiapine and its clinical applications in schizophrenia.","volume":"I","author":"Kasper","year":"2000","journal-title":"Exp Opin Pharmacother"},{"issue":"1","key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2190\/WM5V-D9Y2-2HYW-VGWX","article-title":"Quetiapine in the successful treatment of schizophrenia with co-morbid alcohol and drug dependence: a case report.","volume":"33","author":"Weisman","year":"2003","journal-title":"Int J Psychiatry Med"},{"issue":"2","key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/1568007024606230","article-title":"Treatment of schizophrenia and co-morbid substance use disorder.","volume":"1","author":"Green","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"5","key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2165\/00023210-200115050-00006","article-title":"Sleep abnormalities during abstinence in alcohol-dependent patients: Aetiology and management.","volume":"15","author":"Landolt","year":"2001","journal-title":"CNS Drugs"},{"issue":"3","key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1176\/ajp.153.3.369","article-title":"Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse.","volume":"153","author":"Bremner","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"1","key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1081\/ADA-120018845","article-title":"Comparative profiles of women with PTSD and co-morbid cocaine or alcohol dependence.","volume":"29","author":"Back","year":"2003","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.","volume":"23","author":"Monnelly","year":"2003","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"R18-10-20210128","first-page":"1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry.","volume":"159","author":"Stein","year":"2002","journal-title":"October"},{"issue":"1","key":"R19-10-20210128","first-page":"15","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol.","volume":"23","author":"Hamner","year":"2003","journal-title":"February"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200410000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:45:25Z","timestamp":1785786325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200410000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000138763.23482.2a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}